![]() |
市场调查报告书
商品编码
1989023
医疗和保健电子市场预测至2034年—按设备类型、产品类型、技术、应用、最终用户和地区分類的全球分析Medical & Healthcare Electronics Market Forecasts to 2034 - Global Analysis By Device Type (Diagnostic Equipment, Therapeutic Equipment, Monitoring Devices and Surgical Instruments), Product Model, Technology, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的数据,预计到 2026 年,全球医疗和保健电子市场规模将达到 1,981 亿美元,并在预测期内以 7.2% 的复合年增长率增长,到 2034 年将达到 3,455 亿美元。
医疗和保健电子产品专注于支援病患监测、诊断和治疗的设备和技术,旨在提升整体医疗服务品质。此领域涵盖穿戴式装置、影像系统、诊断设备、远端医疗设备和电子健康记录 (EHR) 平台。市场成长的驱动力包括技术创新、慢性病发病率上升以及互联医疗解决方案的日益普及。人工智慧、物联网和分析技术的应用实现了持续监测、预测性医疗和个人化治疗方案的发展。此外,政府支持计划和患者意识的不断提高也推动了医疗电子解决方案在全球范围内的普及和扩展。
根据世界卫生组织(世卫组织)的数据,2021 年全球医疗保健支出达到 9.8 兆美元,其中大部分用于医疗设备和电子健康技术,这反映出人们越来越依赖电子设备进行诊断、监测和治疗。
慢性病增多
糖尿病、心臟病和肺病等慢性疾病的激增正在推动医疗用电子设备的应用。穿戴式装置、监测系统和诊断工具等设备能够实现有效管理、及时介入和早期检测。医疗机构和居家照护越来越依赖这些技术来改善患者照护和治疗效果。随着对高效疾病管理的需求不断增长,医疗服务提供者正在增加对先进医疗用电子设备的投资,而慢性疾病的普遍存在是推动医疗和保健电子市场快速成长的主要因素。
先进医疗设备高成本
昂贵的医疗用电子设备,例如先进的诊断工具、穿戴式健康监测器和人工智慧设备,构成了推广应用的一大障碍,尤其是在新兴市场。小规模医院和诊所面临预算限制,难以投资高成本技术。此外,持续的维护、校准和软体更新也推高了整体支出。虽然这些设备能够改善患者照护和营运效率,但其高昂的价格限制了其广泛应用。因此,成本仍然是医疗和保健电子市场的主要阻碍因素,减缓了市场成长,并限制了资源匮乏地区医疗服务提供者获取这些产品的机会。
远端医疗和远端患者监护的扩展
远端医疗和远端监测的日益普及为医疗用电子设备带来了巨大的成长潜力。穿戴式装置、行动应用程式和连网诊断设备能够实现居家持续健康追踪,从而减少对医院的依赖并改善治疗效果。结合人工智慧分析和电子健康记录,这些技术能够实现个人化医疗。老年人和慢性疾病患者日益增长的需求正在推动新产品创新和市场扩张。这种向居家、技术驱动型医疗保健服务的转变,为製造商和服务供应商提供了部署先进监测解决方案、拓展市场覆盖面以及响应已开发市场和新兴市场以患者为中心的医疗服务趋势的机会。
激烈的竞争与市场饱和
医疗用电子设备产业竞争异常激烈,跨国公司、Start-Ups和区域製造商都在争夺市场份额。这种竞争可能导致价格下降和利润率降低。持续创新需要不断升级产品,进而增加研发投入。成熟市场的饱和限制了成长,也使得产品差异化变得困难。这些压力会阻碍收入成长和整体盈利。为了保持竞争力,企业必须专注于创新、营运效率和策略联盟。因此,激烈的竞争和市场饱和仍然是企业在医疗保健电子市场中维持成长和保持强势地位的重大威胁。
新冠疫情危机医疗用电子设备产业造成了严重衝击,加速了远端医疗和远端监测技术的应用。穿戴式装置、人工呼吸器和连网诊断工具等设备成为管理患者照护、缓解医院拥挤的关键。人工智慧和物联网驱动的系统实现了即时监测、预测分析和更安全的治疗。儘管供应链中断一度导致生产停滞,但政府的干预和紧急资金支持了设备的快速部署。疫情凸显了先进医疗用电子设备的关键作用,推动了创新,加速了市场成长,并促进了全球向互联互通、技术主导的远距远端医疗服务的转型。
在预测期内,诊断设备细分市场预计将占据最大的市场份额。
预计在预测期内,诊断设备领域将占据最大的市场份额,因为它在早期检测、精准诊断和预防医学方面发挥着至关重要的作用。影像系统、临床实验室设备和就地检验设备等设备广泛应用于医院、诊所和检查室。慢性病和感染疾病的上升,以及人工智慧、物联网和影像技术的创新,正在推动市场需求。医疗服务提供者将诊断作为优先事项,以实现快速干预并改善患者预后,这使得该领域成为医疗和保健电子行业的关键驱动力和重点关注领域。
预计人工智慧和机器学习应用领域在预测期内将呈现最高的复合年增长率。
在预测期内,人工智慧和机器学习应用领域预计将呈现最高的成长率,这主要得益于其革新诊断、监测和个人化医疗的能力。这些技术能够处理来自穿戴式装置、影像系统和电子健康记录的大量健康数据,从而识别疾病的早期征兆、预测患者预后并优化治疗策略。对智慧化、分析主导医疗保健解决方案日益增长的需求,以及人工智慧设备和平台在医院和远端医疗的广泛应用,预计将推动该领域实现最高成长。这正是医疗和保健电子产业创新、营运效率提升和患者照护水准提升的关键驱动力。
在整个预测期内,北美预计将保持最大的市场份额,这主要得益于其先进的医疗保健体系、数位化解决方案的普及以及政府的支持。领先的医疗设备製造商、研究中心和技术型医院正在推动人工智慧、物联网和连线健诊工具的快速应用。慢性病盛行率的上升、人口老化以及健康意识的增强,都推动了对诊断、监测和治疗设备的需求。大量的研发投入、优惠的报销政策以及强有力的监管支持,巩固了该地区的领先地位,使北美成为全球医疗和健康电子行业增长的主要驱动力。
在预测期内,亚太地区预计将呈现最高的复合年增长率,这主要得益于医疗保健支出不断增长、健康意识日益增强以及尖端医疗技术的快速普及。医院和医疗网络的扩张,以及政府的支持性项目,正在推动对诊断、监测和治疗设备的需求。庞大的人口基数、慢性病发病率的上升以及远距远端医疗、穿戴式装置和人工智慧解决方案的日益普及,都促进了市场的快速成长。对医疗基础设施和技术创新的持续投资将使亚太地区成为成长最快的地区,提供巨大的商业机会,并崛起为全球医疗和健康电子产业的主要成长中心。
According to Stratistics MRC, the Global Medical & Healthcare Electronics Market is accounted for $198.1 billion in 2026 and is expected to reach $345.5 billion by 2034 growing at a CAGR of 7.2% during the forecast period. Medical & Healthcare Electronics focuses on devices and technologies that aid in patient monitoring, diagnosis, and treatment, improving overall healthcare delivery. This domain covers wearables, imaging systems, diagnostic instruments, telehealth devices, and electronic health record platforms. Market growth is fueled by technological innovation, increasing chronic disease rates, and the rising use of connected healthcare solutions. Incorporating AI, IoT, and analytics allows for continuous monitoring, predictive care, and tailored treatment plans. Additionally, supportive government programs and heightened patient awareness are driving global adoption and expansion of medical electronic solutions.
According to the World Health Organization (WHO), global healthcare spending reached USD 9.8 trillion in 2021, with a significant portion directed toward medical devices and electronic health technologies, reflecting the increasing reliance on electronics in diagnostics, monitoring, and treatment.
Increasing prevalence of chronic diseases
The surge in chronic diseases like diabetes, heart conditions, and lung disorders is boosting the adoption of healthcare electronics. Devices such as wearables, monitoring systems, and diagnostic tools enable effective management, timely intervention, and early detection. Medical facilities and home-care setups increasingly depend on these technologies for better patient care and outcomes. As demand for efficient disease management grows, healthcare providers are investing more in advanced medical electronics, positioning the prevalence of chronic diseases as a major driver accelerating growth in the medical and healthcare electronics market.
High cost of advanced medical devices
Expensive medical electronics, such as advanced diagnostic tools, wearable health monitors, and AI-enabled devices, act as a barrier to adoption, particularly in emerging markets. Budget constraints in small hospitals and clinics prevent investment in high-cost technologies. Additionally, ongoing maintenance, calibration, and software updates raise the total expenditure. Even though these devices enhance patient care and operational efficiency, their high price limits widespread implementation. Consequently, the cost factor remains a key restraint for the medical and healthcare electronics market, slowing growth and restricting accessibility for healthcare providers in resource-limited regions.
Expansion of telehealth and remote patient monitoring
The increasing adoption of telemedicine and remote monitoring offers substantial growth potential for healthcare electronics. Wearables, mobile apps, and connected diagnostic devices facilitate continuous health tracking at home, lowering hospital dependency and improving outcomes. Coupled with AI analytics and electronic health records, these technologies enable personalized care. Rising demand from elderly and chronic patients drives new product innovation and market expansion. This shift toward home-based, tech-enabled healthcare services creates opportunities for manufacturers and service providers to introduce advanced monitoring solutions, expand market reach, and cater to patient-centered care trends in both developed and emerging regions.
Intense competition and market saturation
The medical electronics sector is highly competitive, with multinational corporations, startups, and regional manufacturers vying for market share. This rivalry can result in price reductions and thinner margins. Continuous innovation requires constant product upgrades, raising R&D expenditures. Saturation in mature markets limits growth, making it difficult to differentiate products. Such pressures can hinder revenue expansion and overall profitability. To stay competitive, companies must focus on innovation, operational efficiency, and strategic alliances. Consequently, intense competition and market saturation remain critical threats, challenging firms to sustain growth and maintain a strong position in the medical and healthcare electronics market.
The COVID-19 crisis profoundly impacted the medical electronics sector, driving faster adoption of telehealth and remote monitoring technologies. Devices such as wearables, ventilators, and connected diagnostic tools became essential for managing patient care while reducing hospital congestion. AI and IoT-enabled systems allowed real-time monitoring, predictive analytics, and safer treatment. Although supply chain interruptions temporarily hindered production, government interventions and emergency funding supported rapid device deployment. The pandemic emphasized the critical role of advanced medical electronics, fostering innovation, accelerating market growth, and promoting a global transition toward connected, technology-driven, and remote healthcare services.
The diagnostic equipment segment is expected to be the largest during the forecast period
The diagnostic equipment segment is expected to account for the largest market share during the forecast period due to its essential role in early detection, precise diagnosis, and preventive care. Tools such as imaging systems, laboratory analyzers, and point-of-care testing devices are extensively used in hospitals, clinics, and labs. The increasing incidence of chronic and infectious diseases, alongside innovations in AI, IoT, and imaging technologies, drives demand. Healthcare providers emphasize diagnostics to enable prompt intervention and improved patient outcomes, positioning this segment as a primary growth driver and a core area of focus within the medical and healthcare electronics industry.
The AI & machine learning applications segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the AI & machine learning applications segment is predicted to witness the highest growth rate, fueled by their ability to revolutionize diagnostics, monitoring, and individualized care. These technologies process extensive health data from wearables, imaging systems, and electronic records to identify early disease signs, forecast patient outcomes, and enhance treatment strategies. Rising demand for intelligent, analytics-driven healthcare solutions, along with expanding use of AI-enabled devices and platforms in hospitals and remote care, positions this segment as the highest-growing. It is a key driver of innovation, operational efficiency, and advanced patient care in the medical and healthcare electronics industry.
During the forecast period, the North America region is expected to hold the largest market share, fueled by advanced healthcare systems, widespread use of digital solutions, and supportive government initiatives. Major medical device companies, research centers, and tech-focused hospitals facilitate rapid adoption of AI, IoT, and connected healthcare tools. Increasing chronic disease prevalence, aging demographics, and higher health awareness boost demand for diagnostic, monitoring, and therapeutic devices. Substantial R&D investments, favorable reimbursement schemes, and strong regulatory support reinforce the region's dominance, positioning North America as the leading contributor to the global growth of the medical and healthcare electronics industry.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by higher healthcare expenditure, growing health awareness, and quick adoption of modern medical technologies. Expansion of hospitals, healthcare networks, and supportive government programs boost demand for diagnostic, monitoring, and therapeutic devices. A large population, rising chronic disease incidence, and growing use of telemedicine, wearable devices, and AI-powered solutions contribute to rapid market expansion. Sustained investments in healthcare infrastructure and technological innovation make Asia Pacific the highest-growth rate region, offering significant opportunities and emerging as a leading growth hub in the global medical and healthcare electronics sector.
Key players in the market
Some of the key players in Medical & Healthcare Electronics Market include Analog Devices, Inc., TE Connectivity, Texas Instruments Incorporated, STMicroelectronics, NXP Semiconductors, Infineon Technologies AG, GE HealthCare, Microchip Technology Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Becton, Dickinson and Company, Dragerwerk AG & Co. KGaA and Stryker.
In October 2025, Infineon Technologies AG has signed power purchase agreements (PPA) with PNE AG and Statkraft to procure wind and solar electricity for its German facilities. Under a 10-year deal with German renewables developer and wind power producer PNE AG, Infineon will buy electricity from the Schlenzer and Kittlitz III wind farms in Brandenburg, Germany, which have a combined capacity of 24 MW, for its sites in Dresden, Regensburg, Warstein and Neubiberg near Munich.
In February 2025, NXP Semiconductors has acquired AI chip startup Kinara in a $307 million all-cash agreement. NXP said the acquisition would enable it to "enhance and strengthen" its ability to provide scalable AI platforms by combining Kinara's NPUs and AI software with NXP's solutions portfolio. Kinara develops programmable neural processing units (NPUs) for Edge AI applications, including multi-modal generative AI models.
In December 2024, Texas Instruments (TI) and the U.S. Department of Commerce announced an award agreement of up to $1.6 billion in direct funding through the U.S. CHIPS and Science Act, following the preliminary memorandum of terms announced in August 2024. The funding will help support three of TI's new 300mm wafer fabs currently under construction in Texas and Utah. Support from the CHIPS Act, including the 25% investment tax credit, will help TI provide a geopolitically dependable supply of essential analog and embedded processing semiconductors.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.